Positive Compass Group roadshow feedback: large contracts, GPO expansion, and margin resilience support the Buy thesis

Overview

This report summarizes feedback from an investor meeting held by Goldman Sachs on May 19, 2026 with Compass Group CFO Petros Parras and Head of Investor Relations Agatha Donnelly. The discussion focused on the major University of Kentucky contract, the sustainability of 4-5% net new business growth, long-term margin expansion, GPO strategy expansion, M&A and capital allocation, and investor concerns about food inflation and the potential impact of GLP-1.

Core views

The core view of the report is positive: Compass benefits from scale, breadth of service, and the ability to execute complex contracts in large outsourcing opportunities, with a strong pipeline of opportunities in education and healthcare; the company is expected to achieve approximately 10bps annual margin expansion through operating leverage, underlying margin improvement, GPO benefits, and acquisition synergies; recent M&A has been more accretive to EPS than buybacks as an alternative, and capital allocation for FY27 will be reassessed at the end of FY26; although GLP-1 and food inflation are areas of attention, their impact on the business is currently limited and manageable.

Analysis framework

The analysis is mainly based on management roadshow feedback, recent contract wins, demand in sub-segments, the GPO expansion path, M&A capital allocation, and inflation pass-through mechanisms, combined with Goldman Sachs' views on Compass' long-term EBITA growth, valuation discount, and 12-month target price.

Methodology notes

• Valuation methodsEV/EBITA multiple method

  12-month target price

  Goldman Sachs applies an 18.5x EV/EBITA multiple to its CY27 forecast to derive Compass Group's $40 target price.

• Fundamental researchManagement roadshow feedback

  Management interview and investor meeting

  Through meetings with the CFO and head of investor relations, the report validates key investment theses such as contract wins, long-term net new business growth, margin expansion, GPO, and M&A.

• Factor frameworkGoldman Sachs Factor Profile

  Growth, financial returns, valuation multiples, and composite percentile

  Goldman Sachs Factor Profile compares stocks with the market and industry peers using metrics such as growth, financial returns, and valuation multiples to provide investment context.

• Events and M&AM&A Rank

  Probability tiers for becoming an acquisition target

  Goldman Sachs discloses that its M&A framework assesses the probability of a company becoming an acquisition target on a scale of 1 to 3, but this report focuses more on Compass' capital allocation returns as an acquirer and integrator.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Compass Group (CPG.L)

  Core covered name, rated Buy by Goldman Sachs

  Strengths

  A global leader in contract catering, with advantages in scale procurement, execution of complex contracts, expansion in large education and healthcare deals, GPO expansion, and high ROIC/CROCI returns.

  Weaknesses

  Growth requires continued wins and smooth mobilization of large contracts, while margin expansion depends on operating leverage, GPO execution, and inflation pass-through.

  Comparison

  University of Kentucky was previously served through a mix of Aramark, Compass, and in-house teams, and is now being consolidated under Compass as the sole long-term partner; management believes complex contracts and breadth of service favor scaled operators such as Compass rather than smaller competitors.

  Risks

  Slower net new business growth, lower client retention, macro weakness, margin expansion below expectations, failed M&A integration or overpayment for acquisitions, and foreign exchange volatility.

Key data

• Report date2026-05-19The main text shows the publication time as 19 May 2026 6:32PM BST.
• Rating and target priceBuy; target price $40The target price is based on 18.5x CY27 EV/EBITA.
• Current price on disclosure page$32.73Company-specific disclosures list Compass Group ($32.73) in multiple places.
• Long-term net new business growth target4-5%Management expressed confidence in maintaining this range over the long term.
• Long-term margin expansionApproximately 10bps/yearDrivers include SG&A operating leverage, underlying margin improvement, GPO benefits, and M&A synergies.
• University of Kentucky contract30-year contract; mobilization begins in July 2026Management described it as the largest contract in the industry, about 50% larger than the Texas A&M contract from a decade ago.
• Data center contract$50mnA recently signed data center contract demonstrates momentum in this vertical.
• GPO coverage progressCapabilities already in place in 5 of the top 10 countries; target is to cover markets representing about 90% of profitsThe acquisition of Pro Care Management in Germany enhanced GPO capabilities, with the next phase focused on markets such as France and Spain.
• 1H26 same-store volume growth+0.7%Used to show that the company still delivered solid volume performance despite concerns around GLP-1.
• US food-away-from-home inflationAbout 4%Compass' own tracked figure is below this level, reflecting the advantage of scale procurement.
• Inflation mitigation and pass-throughAbout 40% mitigated; about 60% passed through via pricingIf 2H US food inflation is 1.5 percentage points higher, it could result in about 80-90bps of additional pricing.
• Medium-term growth profileAbout 7% organic growth over the next 5 years; low double-digit organic EPS CAGR; about 3% average dividend yieldGoldman Sachs believes the company is a defensive, high-quality compound growth name.

Impact & implications

The report reinforces the positive investment framework for Compass Group: large education contracts and complex outsourcing opportunities show that its scale advantages are still expanding; GPO and M&A provide additional sources of margin expansion and EPS accretion; food inflation and GLP-1 currently appear more like manageable disruptions than structurally destructive factors. If management delivers 4-5% net new business growth and about 10bps annual margin expansion, the current valuation discount may offer an attractive entry point.

Risks

• Net new business trends may come in weaker than expected, possibly due to lower client retention or fewer new business wins.
• A weaker macro environment may suppress client demand or consumption volumes.
• The pace of margin expansion may be slower than management's approximately 10bps annual target.
• M&A integration may underperform expectations or acquisition prices may be too high, reducing EPS accretion and capital returns.
• Foreign exchange volatility may affect the translation of cross-regional results.
• If 2H food inflation is higher than expected, it may increase pressure on pricing discussions and client acceptance.
• GLP-1 may lead to changes in consumption mix in some health-focused white-collar Business & Industry settings, although management believes the overall impact is limited.

What to watch

• Execution progress and profit contribution after mobilization of the University of Kentucky contract begins in July 2026.
• Whether the pipeline of large FTO opportunities in education and healthcare continues converting into contract wins.
• The pace of organic expansion or bolt-on M&A to strengthen GPO capabilities in France, Spain, and other European markets.
• Management's choice between buybacks and M&A for FY27 capital allocation at the end of FY26.
• The trajectory of 2H food inflation, Compass' actual cost mitigation, and the effectiveness of passing price increases on to clients.
• Changes in GLP-1 penetration in the US and international markets, and its impact on consumption mix in B&I sub-segments.
• Whether the company continues to deliver about 7% organic growth, low double-digit organic EPS CAGR, and a high-return profile.